Feed NVS
NV
Novartis
NVS · NYSE
$153.83 -0.03% (-$0.04)
1M +3.24%
Market Cap $293.6B
P/E Ratio 20.40x
Div. Yield 3.08%
ROE 34.12%
Bulios Fair Price
$123.43
19.8% downside
Aktuální cena
$153.83
Podhodnoceno Férová hodnota Nadhodnoceno
Valuation
32 /100
Expensive EV/EBITDA 13.78x
P/S 5.21x
P/B 6.62x
Growth
51 /100
Stable Rev. growth 8.04%
FCF growth 13.81%
Book val. growth 8.05%
Profitability
100 /100
Strong Net margin 25.53%
Op. margin 31.15%
FCF margin 30.26%
Quality
68 /100
Excellent ROE 34.12%
ROA 13.42%
Asset turnover 0.53x
Debt
58 /100
Moderate Current ratio 0.88x
Int. coverage 15.68x
Net debt/EBITDA 0.98x
Stability
58 /100
Moderate Rev. volatility 2.51%
EPS volatility 72.86%
Profitable years 6
Zeptejte se StockBota na NVS
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Vas Narasimhan
Employees
75,267
Headquarters
Basel
Nadcházející události
27 ŘÍJ
Earnings
Upcoming earnings report